000 01249 a2200361 4500
005 20250512235108.0
264 0 _c19830826
008 198308s 0 0 eng d
022 _a0007-1250
024 7 _a10.1192/bjp.142.3.296
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aQuinn, N P
245 0 0 _aDopa dose-dependent sexual deviation.
_h[electronic resource]
260 _bThe British journal of psychiatry : the journal of mental science
_cMar 1983
300 _a296-8 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAntiparkinson Agents
_xadverse effects
650 0 4 _aBromocriptine
_xadverse effects
650 0 4 _aCarbidopa
_xadverse effects
650 0 4 _aErgolines
_xadverse effects
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aParaphilic Disorders
_xchemically induced
650 0 4 _aParkinson Disease
_xdrug therapy
650 0 4 _aPergolide
700 1 _aToone, B
700 1 _aLang, A E
700 1 _aMarsden, C D
700 1 _aParkes, J D
773 0 _tThe British journal of psychiatry : the journal of mental science
_gvol. 142
_gp. 296-8
856 4 0 _uhttps://doi.org/10.1192/bjp.142.3.296
_zAvailable from publisher's website
999 _c6860617
_d6860617